ClinicalTrials.gov Identifier: NCT01358266
32-007: Phase 3 study of Intravitreal injections of DE-109 in patiens with active, non-infectious uveitis of the posterior segment of the eye.
Condition: Uveitis; Posterior, Disorder
Study Type: Interventional
Duration: 5 years and 7 months
For additional information on this study, please click hereBack to Clinical Research